Keywords: Minapharm, ProBiogen, Buys 95% stake, M&A
Egypt’s Minapharm takes 95% stake in Germany’s ProBioGen for around $37 million
Article | 17 June 2010
Egyptian drugmaker Minapharm Pharmaceuticals says it has completed the acquisition of 95% of the share capital of ProBioGen AG, a German ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
